Growth Hormone
Growth Hormone is a key hormone produced by the pituitary gland that regulates growth, cell reproduction, and metabolism in the human body.
Growth Hormone (GH), also known as somatotropin, is a peptide hormone secreted by the anterior pituitary gland that plays a crucial role in stimulating growth, cell reproduction, and cell regeneration in humans and other animals. It is essential for normal physical growth in children and adolescents and maintains various metabolic functions throughout adulthood. GH influences multiple tissues and organs, promoting anabolic effects and regulating metabolism, primarily through its interaction with the Growth Hormone-Insulin-like Growth Factor (GH-IGF) signaling axis.
Molecular Structure and Synthesis
Molecular Composition
Growth Hormone is a single-chain polypeptide composed of 191 amino acids in humans, with a molecular weight of approximately 22 kDa. It belongs to the class of protein hormones and has a complex tertiary structure stabilized by two disulfide bridges. GH is encoded by the GH1 gene located on chromosome 17.
Synthesis and Secretion
GH is synthesized by somatotroph cells in the anterior pituitary gland. Its secretion is pulsatile and regulated by hypothalamic hormones: Growth Hormone-Releasing Hormone (GHRH) stimulates release, while somatostatin inhibits it. Additional modulators include ghrelin, which enhances secretion, and feedback mechanisms involving IGF-1 and metabolic signals such as glucose and free fatty acid levels.
Secretion peaks during deep sleep phases and varies with age, being highest during puberty and progressively declining in adulthood.
Physiological Functions
Promotion of Growth
GH exerts its growth-promoting effects largely by stimulating the liver and other tissues to produce Insulin-like Growth Factor 1 (IGF-1), which mediates many of GH’s anabolic actions. IGF-1 acts in an endocrine, paracrine, and autocrine manner to promote the proliferation of chondrocytes in the growth plates of long bones, leading to linear bone growth.
Metabolic Effects
- Protein Metabolism: GH enhances amino acid uptake and protein synthesis in muscle and other tissues, promoting muscle growth and repair.
- Carbohydrate Metabolism: It has anti-insulin effects, reducing glucose uptake by cells and promoting gluconeogenesis in the liver, which can increase blood glucose levels.
- Lipid Metabolism: GH stimulates lipolysis, mobilizing fatty acids from adipose tissue to be used as an energy source, thereby reducing fat mass.
Maintenance of Body Composition
By promoting lean body mass accumulation and reducing adiposity, GH helps maintain a favorable body composition. This effect is critical in regulating energy balance and metabolic health.
Regulation of Growth Hormone Secretion
Hypothalamic Control
- Growth Hormone-Releasing Hormone (GHRH): Secreted by the hypothalamus, GHRH stimulates GH release.
- Somatostatin (Growth Hormone-Inhibiting Hormone): Also produced in the hypothalamus, somatostatin inhibits GH secretion.
Feedback Mechanisms
- IGF-1 Negative Feedback: Circulating IGF-1, produced mainly by the liver under GH stimulation, exerts negative feedback on both the pituitary and hypothalamus, reducing GH secretion.
- Metabolic Signals: Blood glucose, free fatty acids, and other metabolic cues influence GH secretion to maintain homeostasis.
Other Influences
- Sleep: GH secretion peaks during slow-wave sleep.
- Exercise and Stress: Physical activity and physiological stress stimulate GH release.
- Nutritional Status: Fasting increases GH secretion, while obesity decreases it.
Growth Hormone Receptors and Signaling Pathways
Growth Hormone Receptor (GHR)
GH acts by binding to the Growth Hormone Receptor, a transmembrane protein belonging to the cytokine receptor superfamily, expressed on the surface of various target cells including liver, muscle, bone, and adipose tissue.
Signal Transduction
Upon GH binding, GHR undergoes dimerization and activates intracellular signaling cascades primarily through:
- JAK2-STAT Pathway: Janus kinase 2 (JAK2) is recruited and activated, phosphorylating Signal Transducer and Activator of Transcription (STAT) proteins, mainly STAT5, which translocate to the nucleus to regulate gene expression.
- MAPK Pathway: Mitogen-activated protein kinase (MAPK) pathways contribute to mitogenic and differentiation signals.
- PI3K-AKT Pathway: Phosphoinositide 3-kinase (PI3K) and AKT signaling support metabolic effects.
These cascades lead to the expression of IGF-1 and other growth-related genes, mediating the physiological effects of GH.
Clinical Significance
Growth Hormone Deficiency
Insufficient GH secretion in children results in growth retardation and short stature, known as pituitary dwarfism. In adults, GH deficiency can cause decreased muscle mass, increased fat mass, reduced bone density, and impaired quality of life.
Growth Hormone Excess
Excessive GH secretion leads to gigantism in children (before epiphyseal plate closure) and acromegaly in adults, characterized by abnormal enlargement of bones and soft tissues, metabolic disturbances, and increased morbidity.
Therapeutic Use
Recombinant human Growth Hormone (rhGH) is used to treat GH deficiency, chronic kidney disease-associated growth failure, Turner syndrome, Prader-Willi syndrome, and other conditions. GH therapy requires careful monitoring to avoid adverse effects like glucose intolerance and edema.
Diagnostic Use
GH levels are measured to assess pituitary function. Due to pulsatile secretion, provocative tests (e.g., insulin tolerance test) are often employed to evaluate GH reserve.
Interaction with the IGF System
GH primarily exerts its growth-promoting actions through stimulation of IGF-1 production. IGF-1 mediates systemic endocrine effects and local tissue growth via autocrine and paracrine mechanisms. The GH-IGF axis maintains growth, metabolism, and tissue repair.
IGF-binding proteins (IGFBPs) regulate IGF-1 bioavailability and activity, modulating the balance between growth signals and metabolic control.
Summary of Key Characteristics
| Characteristic | Description |
|---|---|
| Hormone Type | Peptide protein |
| Source | Anterior pituitary somatotrophs |
| Molecular Weight | ~22 kDa |
| Amino Acids | 191 |
| Main Target Organs | Liver, bone, muscle, adipose tissue |
| Receptor | Growth Hormone Receptor (GHR) |
| Major Mediator | Insulin-like Growth Factor 1 (IGF-1) |
| Regulation | GHRH (+), Somatostatin (-), IGF-1 feedback |
| Clinical Disorders | GH deficiency, acromegaly, gigantism |
This comprehensive overview captures the critical aspects of Growth Hormone, including its biology, regulation, physiological roles, signaling mechanisms, and clinical relevance within the endocrine system.